Big Easy Weight Loss | Metairie, Louisiana | Serving patients in 49 states via telemedicine
Research published in the Journal of Clinical Biochemistry and Nutrition found that acetaldehyde
At Central Pharmacy , we understand the complexities of managing diabetes and are here to help you understand your options
WEIGHT-LOSS DRUGS' IMPACT ON CANCER RISK REVEALED IN NEW STUDY The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and "exacerbating mood disturbances." The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this "potential risk." But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K
Patient education, to include the potential side effects, risks, monitoring parameters, and the importance of follow-up should be documented
doi:10.1126/science.6147899